We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FSB
1826
DELISTED
Franklin Financial Network, Inc.
FSB
$191K 0.01%
7,440
+5,776
+347% +$135K
CMS icon
1827
CMS Energy
CMS
$21.7B
$190K 0.01%
3,249
-1,872
-37% -$108K
UPWK icon
1828
Upwork
UPWK
$1.21B
$190K 0.01%
+13,124
New +$138K
MDC
1829
DELISTED
M.D.C. Holdings, Inc.
MDC
$190K 0.01%
5,739
+5,648
+6,207% +$156K
ACA icon
1830
Arcosa
ACA
$7.11B
$189K 0.01%
4,480
+4,152
+1,266% +$160K
EQX icon
1831
Equinox Gold
EQX
$13.5B
$189K 0.01%
16,826
+12,912
+330% +$116K
PLUS icon
1832
ePlus
PLUS
$2.35B
$189K 0.01%
+5,344
New +$182K
RJF icon
1833
Raymond James Financial
RJF
$34.5B
$189K 0.01%
4,112
+752
+22% +$33.9K
SPDW icon
1834
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$41.4B
$189K 0.01%
6,834
+5,934
+659% +$155K
UYG icon
1835
ProShares Ultra Financials
UYG
$851M
$189K 0.01%
+6,501
New +$181K
ICPT
1836
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$189K 0.01%
+3,956
New +$306K
INDT
1837
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$189K 0.01%
+3,481
New +$144K
CUE icon
1838
Cue Biopharma
CUE
$110M
$188K 0.01%
+255
New +$185K
CYBR
1839
DELISTED
CyberArk
CYBR
$188K 0.01%
1,892
+1,105
+140% +$108K
EEFT icon
1840
Euronet Worldwide
EEFT
$2.65B
$188K 0.01%
1,967
+1,578
+406% +$146K
USPH icon
1841
US Physical Therapy
USPH
$1.22B
$188K 0.01%
+2,315
New +$169K
FSS icon
1842
Federal Signal
FSS
$7.74B
$187K 0.01%
6,291
+2,238
+55% +$63.3K
HLF icon
1843
Herbalife
HLF
$1.21B
$186K 0.01%
4,138
-278
-6% -$10.8K
HPE icon
1844
Hewlett Packard
HPE
$72.4B
$186K 0.01%
19,083
+10,886
+133% +$107K
SFBS
1845
ServisFirst Bancshares
SFBS
$4.84B
$186K 0.01%
+5,215
New +$172K
EE
1846
DELISTED
El Paso Electric Company
EE
$186K 0.01%
+2,778
New +$188K
GLW icon
1847
Corning
GLW
$136B
$185K 0.01%
7,153
+725
+11% +$16.4K
RCKT icon
1848
Rocket Pharmaceuticals
RCKT
$397M
$185K 0.01%
+8,858
New +$160K
VXUS icon
1849
Vanguard Total International Stock ETF
VXUS
$162B
$185K 0.01%
+3,769
New +$174K
EPAY
1850
DELISTED
Bottomline Technologies Inc
EPAY
$185K 0.01%
+3,653
New +$163K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.